Fresenius recalls drug vials due to glass specs

WASHINGTON (AP) — The American unit of German drugmaker Fresenius is recalling four lots of an injectable drug after finding particles of glass in some vials of the medication.

The recall applies to four lots of benztropine mesylate injection, which is used to treat Parkinson’s disease and some movement side effects related to epilepsy drugs. The drug is manufactured by Allergy Laboratories Inc. and distributed by Fresenius Kabi. The products may also appear with APP or Nexus Pharmaceuticals listed as the manufacturer on the label. The recalled lot numbers are: 030712, 071212, 090512 and 111412.

Fresenius Kabi USA says no adverse reactions or customer complaints have been reported.

The company is asking health care professionals to return the products by calling the company at 1-866-716-2459.

___

On the Web: http://www.apppharma.com/our-products/product-updates3

WKBN 27 First News provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. No links will be permitted. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

blog comments powered by Disqus